- Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. Rich, P., Griffiths, C.E., Reich, K., Nestle, F.O., Scher, R.K., Li, S., Xu, S., Hsu, M.C., Guzzo, C. J. Am. Acad. Dermatol. (2008)